Slingshot Biosciences Appoints Jim Snook as Senior Vice President, Global Sales
March 5, 2026
Industry veteran brings extensive life sciences commercial leadership experience from Biotechne, Miltenyi Biotec, and Adaptive Biotechnologies EMERYVILLE, Calif. -- Slingshot Biosciences, the pioneer of synthetic cell mimic technology for flow cytometry controls, today announced the appointment of Jim Snook as Senior Vice President, Global Sales. In this role, Snook will lead the company's rapidly growing global [...]
March 5, 2026
FastHDX unlocks millisecond HDX-MS, delivering a 4-5 order-of-magnitude leap in labeling resolution and revealing fast, transient protein dynamics that conventional structural biology methods miss. Early adopter results from top pharmaceutical and academic institutions validate FastHDX for probing transient allosteric states in disease-relevant systems including diabetes, cancer, and Parkinson's disease. Seamless integration with standard LC-MS workflows, [...]
March 5, 2026
Dataset grows to more than 312,000 whole genomes with longitudinal clinical data GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance for Genomic Discovery (AGD [...]
Rigaku Launches NEX QC II Series Benchtop XRF Analyzers for Industrial QC at Pittcon 2026
March 5, 2026
Fast, reliable elemental analysis built for daily quality control and production use Cedar Park, Texas -- Applied Rigaku Technologies, a division of Rigaku group (Headquarters: Akishima, Tokyo; CEO: Jun Kawakami), announces the release of its NEX QC II Series benchtop X-ray fluorescence (XRF) analyzers at Pittcon 2026, held March 7–11 in San Antonio, Texas, USA. Pittcon [...]
March 4, 2026
Appoints Frederik Decouttere as CEO LAUSANNE, Switzerland -- Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several [...]
March 4, 2026
Contributing to Cancer Research with Technology that Visualizes Multi-layered Omics Information on Microscopic Images Superimposing multiple spatial omics information onto a microscopic image TOKYO – Nikon Corporation (Nikon) is pleased to announce that its software technology, developed to visualize multiple layers of spatial omics information *1 on microscopic images, was used in joint research led by [...]
March 4, 2026
MONMOUTH JUNCTION, N.J. -- TheWell Bioscience, a leader in advanced xeno-free cell culture technologies, today announced the launch of RocketCell™ hMSC Xeno-Free Complete Growth Medium, a chemically defined, xeno-free medium engineered for high-performance human mesenchymal stem cell (hMSC) expansion and exosome production across research, translational development, and cell therapy manufacturing workflows. As regulatory agencies and industry [...]
March 4, 2026
MADISON, Wis. -- BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies in pain biology, sensory transduction, and ion channel pharmacology. BrainXell sensory neurons demonstrate robust expression of hallmark sensory neuron genes and proteins, including voltage-gated sodium channels [...]
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
March 4, 2026
BURLINGTON, Mass. -- Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash [...]
Sartorius launches rational-design CHO host cell line with up to three-fold increase in productivity
March 3, 2026
New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold increase in productivity Host provides robust, long-term genetic and phenotypic stability, supporting reliable performance and providing greater confidence through scale-up and regulatory milestones Göttingen, Germany -- Sartorius is addressing the increasing demand for faster and more efficient [...]

